Nicholas Lorusso

Stock Analyst at TD Cowen

(3.19)
# 2,455
Out of 4,581 analysts
13
Total ratings
62.5%
Success rate
21.7%
Average return

Stocks Rated by Nicholas Lorusso

Kiniksa Pharmaceuticals International,
Jul 28, 2026
Maintained: Buy
Price Target: $65$95
Current: $79.44
Upside: +19.59%
Immatics
Jun 17, 2026
Maintained: Buy
Price Target: n/a
Current: $8.74
Upside: -
Keros Therapeutics
May 14, 2026
Maintained: Hold
Price Target: n/a
Current: $10.07
Upside: -